Posts by Sandra Ansanay-Alex
Oculis Raises $110 Million to Accelerate its Development
The Swiss-Icelandic ophthalmology company Oculis, based in Zug with its operational headquarters in Lausanne, has completed an oversubscribed capital increase of $110 million. This is its second fundraising round exceeding $100 million in less than a year, following the one in February. Net proceeds from the financing will be used to advance and accelerate the…
Read MoreCHUV and HUG among Europe’s most innovative hospitals
The university hospitals of the Swiss Health Valley confirm their scientific excellence, placing Switzerland among the select group of nations most dynamic in hospital research
Read MoreMolesense Raised CHF 150,000 from VentureKick
The Swiss medtech startup’s sweat-based molecular tracking aims to prevent preterm births and empower doctors with continuous, personalised data.
Read MoreTubulis Raises €308 Million Series C
The German company, that recently set foot at Biopôle Lausanne, generates antibody-drug conjugates to fight ovarian cancer and lung adenocarcinomas.
Read MoreONWARD Medical Raised €50 Million in Capital Increase
ONWARD Medical, a leading neurotechnology company headquartered in the Netherlands, with R&D operations in Lausanne Switzerland and a US office in Boston, is developing therapies to restore movement and independence in people with spinal cord injuries, and has successfully raised over €50 million through a private placement of new shares. The capital increase, backed by…
Read MoreRed Drop Receives a FIT Impact Grant
Red Drop offers home self-sampling kits that use menstrual blood to obtain health information and receive healthcare support.
Read MoreSihuan Pharmaceutical Invests in Suisselle SA
Sihuan Pharmaceutical Holdings Group (HKG:0460) announced that it has made a capital investment in Swiss medical aesthetics company Suisselle, according to a statement released on Monday to the Hong Kong Stock Exchange. The pharmaceutical group did not disclose the financial terms of the transaction. Sihuan Pharmaceutical previously obtained the exclusive distribution rights for Suisselle’s CELLBOOSTER®…
Read MorePartial heart transplant performed at HUG, a European first
This highly technical procedure was carried out on a 12-year-old patient with complex congenital heart disease.
Read MoreSOPHiA GENETICS Launches AI-Powered Digital Twins to Enhance Intelligent Decision-Making in Oncology
SOPHiA GENETICS is a leader in AI-driven precision medicine based in Lausanne (Switzerland). The company announced the launch of SOPHiA DDM™ Digital Twins, a breakthrough research technology that creates dynamic, virtual representations of individual patients to simulate potential outcomes and help oncologists make better treatment decisions. SOPHiA DDM™ Digital Twins uses each patient’s unique…
Read More19th Innovation Day at HUG: Meet the Winners!
At their 19th Innovation Day, the Geneva University Hospitals (HUG) highlighted 16 innovative projects from the hospital and academic sectors, grouped into three categories: Proof of Concept, Prototype, and Launch-Ready Product. Top 3 Awarded Projects: 🥇 Flow Twin: A 3D modeling platform of brain vessels for training, planning personalized endovascular procedures, and testing new…
Read More